Medtech Insight covered significant takeaways from the Digital Therapeutics Alliance Annual Summit, highlighting Member Daniel Cody’s perspective of the challenges posed by payer-driver demands for digital therapeutics to be treated like prescription drugs. 

Dan said, “We’ve gotten to this place because of payers. Payers really wanted these products to be prescription drugs. That was the only way they could comprehend it. At the end of the day, we need a separate benefit category, but that’s going to take time.”

Source

Medtech Insight